Overview

Siemens Healthineers AG is a German medical technology company headquartered in Erlangen and operating internationally across medical imaging, laboratory diagnostics, cancer care, and image-guided and minimally invasive therapies. The company is the healthcare technology business associated with Siemens AG and serves hospitals, diagnostic laboratories, outpatient providers, research institutions, and other clinical customers. Its portfolio spans equipment, consumables, software, digital services, workflow systems, and long-term service arrangements rather than being limited to individual medical devices. The business traces its corporate and technological ancestry to Siemens & Halske, founded in Berlin in 1847 by Werner von Siemens and Johann Georg Halske. Siemens entered medical technology during the nineteenth century and produced industrially manufactured X-ray tubes soon after the discovery of X-rays. Over the following decades, the business expanded through work in radiology, ultrasound, cardiology, laboratory automation, computed tomography, magnetic resonance imaging, molecular imaging, and radiotherapy. Several historical acquisitions and combinations, including the integration of X-ray businesses into Siemens-Reiniger-Werke, helped establish the foundations of the modern healthcare division. Important innovations associated with the business include early rotating-anode X-ray tubes, echocardiography applications, implanted pacemaker technology developed through Elema-Schönander, real-time ultrasound, computed tomography scanners, automated laboratory systems, and hybrid imaging. Siemens was also an early commercial developer of combined positron-emission tomography and computed tomography systems, and later introduced integrated PET/MR technology. These products positioned the company around the combination of anatomical, functional, and molecular information for diagnosis and treatment planning. The healthcare division was called Siemens Medical Solutions from 2001 and Siemens Healthcare from 2008. In 2016 Siemens introduced the Siemens Healthineers name as part of a broader management and brand strategy. The name was subsequently used for the standalone public company created through a partial spin-off from Siemens AG. Siemens Healthineers began trading on the Frankfurt Stock Exchange on 16 March 2018 after Siemens sold a minority stake. Siemens AG retained majority ownership and remains the company's controlling shareholder. The company organizes its activities around imaging, diagnostics, and advanced therapies. Imaging includes magnetic resonance, computed tomography, molecular imaging, X-ray, angiography, and ultrasound. Diagnostics includes laboratory analyzers, assays, point-of-care testing, and laboratory automation. Advanced therapies include image-guided interventions, radiation oncology, surgical technologies, and related digital planning and workflow solutions. The company also provides managed services, clinical consulting, equipment maintenance, and software intended to improve utilization and operational efficiency. Siemens Healthineers has faced criticism as well as commercial and strategic scrutiny. The 2016 brand launch attracted unfavorable commentary because of its name, logo, and launch performance. In 2022, the company's decision to continue supplying and servicing healthcare-related operations in Russia after Russia's invasion of Ukraine drew criticism, particularly in comparison with Siemens AG's decision to withdraw from the Russian market. Siemens Healthineers defended its position by emphasizing the provision of healthcare products and services. The company remains an active global medtech business under Siemens AG's majority ownership.

History

Siemens Healthineers's history combines the development of Siemens AG with the evolution of modern medical technology. The corporate lineage begins with Siemens & Halske, established in Berlin on 12 October 1847 by Werner von Siemens and Johann Georg Halske. Initially focused on telegraphy and electrical engineering, the company gradually expanded into electromedical equipment and healthcare technologies. The discovery of X-rays in the 1890s created an early opportunity for Siemens. In 1896, the company produced industrially manufactured X-ray tubes for medical diagnosis. X-ray specialist Friedrich Dessauer later founded a business that became known as Veifa-Werke. Its relationship with Siemens eventually contributed to the 1932 formation of Siemens-Reiniger-Werke, an important predecessor of the later healthcare organization. In 1933 Siemens introduced rotating-anode X-ray tubes, which were designed to tolerate higher electrical loads and became important to the development of diagnostic radiology. During the postwar period, Siemens-related engineers and collaborators contributed to several areas of clinical technology. In 1953, physician Inge Edler and physicist Carl Hellmuth Hertz used ultrasound for echocardiography, helping establish ultrasound as a method for examining the heart. In 1958, Elema-Schönander, later associated with Siemens-Elema, developed an implanted cardiac pacemaker used in a critically ill patient. In the 1960s, Siemens engineer Ralph Soldner developed the Vidoson, an early real-time ultrasound system that allowed clinicians to observe movement inside the body on a screen during scanning. Siemens became a major participant in cross-sectional imaging. In 1974, it presented an early tomographic image of a human head at the Radiological Society of North America meeting in Chicago. The following year it released the Siretom computed tomography scanner. The company later expanded into magnetic resonance imaging, molecular imaging, angiography, radiotherapy, and ultrasound. Its diagnostic laboratory activities also grew: in 1998, Siemens introduced ADVIA LabCell, described as the first track-based laboratory automation system. The business was renamed Siemens Medical Solutions in 2001 and Siemens Healthcare in 2008. It developed hybrid imaging as a major area of differentiation. Siemens combined PET, which shows biological and metabolic activity, with CT, which provides detailed anatomical information. The resulting Biograph platform became an early commercial PET/CT system and was recognized by Time magazine as an innovation of the year in 2000. In 2010, Siemens launched Biograph mMR, combining PET and MRI in one system. These technologies supported the use of multiple forms of clinical information for diagnosis, research, and treatment planning. The company also narrowed parts of its portfolio. In 2011, Siemens discontinued its linear accelerators for cancer treatment, citing cost pressures and a strategic focus on diagnostic imaging in oncology. The healthcare business adopted the Siemens Healthineers brand in May 2016. The launch generated substantial public criticism over the unusual name, logo comparisons, and an elaborate promotional dance associated with the unveiling. Chief executive Bernd Montag later acknowledged that the dance presentation had been a mistake. Siemens Healthineers was separated from Siemens AG through a partial public offering. In November 2017 the company announced its intention to list on the Frankfurt Stock Exchange. Trading began on 16 March 2018 after Siemens sold a minority stake, while retaining majority ownership. Since then, Siemens Healthineers has continued as a global medical technology group serving imaging, diagnostics, laboratory medicine, intervention, cancer care, and healthcare software markets. Its modern strategy emphasizes integrated systems, workflow automation, digital services, and the connection of diagnosis with minimally invasive treatment. The company attracted further criticism in 2022 for retaining operations in Russia after the invasion of Ukraine, arguing that healthcare-related products and services should continue to be provided.

2018
Frankfurt Stock Exchange listing
[1]Siemens Healthineersen.wikipedia.org
Siemens Healthineers begins public trading after Siemens AG sells a minority stake.
2016
Siemens Healthineers brand launched
[1]Siemens Healthineersen.wikipedia.org
Siemens Healthcare adopts the Siemens Healthineers name and identity.
2011
Linear accelerator business discontinued
[1]Siemens Healthineersen.wikipedia.org
Siemens exits its linear-accelerator business for cancer treatment, citing cost pressures and a diagnostic-imaging focus.
2010
Biograph mMR introduced
[1]Siemens Healthineersen.wikipedia.org
Siemens launches an integrated PET/MR scanner combining metabolic and anatomical imaging.
2008
Siemens Healthcare name introduced
[1]Siemens Healthineersen.wikipedia.org
The business is renamed Siemens Healthcare.
2001
Healthcare business becomes Siemens Medical Solutions
[1]Siemens Healthineersen.wikipedia.org
The healthcare business adopts the Siemens Medical Solutions name.
1998
ADVIA LabCell automation
[1]Siemens Healthineersen.wikipedia.org
Siemens introduces ADVIA LabCell, a track-based laboratory automation solution.
1975
Siretom CT scanner
[1]Siemens Healthineersen.wikipedia.org
Following an earlier tomographic demonstration, Siemens releases the Siretom computed tomography scanner.
1960
Vidoson real-time ultrasound
[1]Siemens Healthineersen.wikipedia.org
Siemens engineer Ralph Soldner develops the Vidoson, an early real-time ultrasound system.
1958
Implantable pacemaker technology
[1]Siemens Healthineersen.wikipedia.org
Elema-Schönander develops an implanted cardiac pacemaker later associated with Siemens-Elema.
1953
Ultrasound echocardiography milestone
[1]Siemens Healthineersen.wikipedia.org
Inge Edler and Carl Hellmuth Hertz use ultrasound for echocardiography in work supported by Siemens.
1932
Siemens-Reiniger-Werke is formed
[1]Siemens Healthineersen.wikipedia.org
Siemens and the Veifa-Werke business associated with Friedrich Dessauer combine to form Siemens-Reiniger-Werke.
1896
Early industrial medical X-ray tubes
[1]Siemens Healthineersen.wikipedia.org
Siemens produces industrially manufactured X-ray tubes shortly after the discovery of X-rays.
1847
Siemens & Halske is founded
[1]Siemens Healthineersen.wikipedia.org
Werner von Siemens and Johann Georg Halske establish the Berlin electrical engineering company that provides the corporate ancestry for Siemens Healthineers.

Products and positioning

High-end, integrated medical technology spanning diagnosis, clinical decision-making, image-guided intervention, and treatment, with emphasis on combining hardware, software, automation, and service capabilities.

Magnetic resonance imaging
MAGNETOM
MAGNETOM is Siemens Healthineers's family of magnetic resonance imaging systems. The platform is used to generate detailed images of soft tissue and other body structures without ionizing radiation. Systems in the family serve hospitals, imaging centers, and research environments, with configurations designed for different clinical workloads, field strengths, body regions, and workflow requirements.
Computed tomography · 1975
SOMATOM
SOMATOM is the company's computed tomography portfolio. These systems use X-rays and computer reconstruction to produce cross-sectional and three-dimensional images. The range supports emergency, routine, cardiovascular, oncology, and advanced imaging applications, with emphasis on speed, dose management, image quality, and integration with clinical workflows.
Molecular and hybrid imaging · 2000
Biograph
Biograph includes Siemens Healthineers hybrid molecular imaging systems, including PET/CT and PET/MR platforms. These systems combine information about anatomy with information about biological or metabolic activity, supporting oncology, neurology, cardiology, research, and treatment planning.
Laboratory diagnostics
Atellica
Atellica is a laboratory diagnostics platform combining analyzers, assays, automation, and software. It is designed for clinical laboratories that need to process multiple types of tests while managing sample movement, instrument utilization, and results workflow. The portfolio covers chemistry, immunoassay, and related laboratory operations.
Laboratory automation · 1998
ADVIA LabCell
ADVIA LabCell is a laboratory automation solution built around track-based sample handling. Introduced in 1998, it represented Siemens's effort to connect analyzers and automate the movement and processing of specimens in high-throughput laboratory environments.
Angiography and image-guided therapy
ARTIS
ARTIS is a family of angiography and image-guided therapy systems. It supports clinicians during minimally invasive cardiovascular, neurovascular, and other interventional procedures by providing live X-ray imaging and procedure-oriented equipment integration.
Ultrasound · 1960
Vidoson
Vidoson was an early real-time ultrasound system developed by Siemens engineer Ralph Soldner in the 1960s. It enabled clinicians to observe internal movement on a display while scanning, helping establish real-time ultrasound as a practical clinical imaging technique.
Computed tomography · 1975
Siretom
Siretom was Siemens's early computed tomography scanner. Released in 1975 after the company presented a tomographic image of a human head, it marked an important step in the commercialization of Siemens cross-sectional imaging technology.

Controversies

2022
Criticism over continued Russian operations
Siemens Healthineers was criticized for continuing healthcare-related business in Russia after the invasion of Ukraine. Critics contrasted this with Siemens AG's announced withdrawal and argued that continued operations weakened economic pressure on Russia. The company cited its commitment to supplying healthcare products and services.
Source
2016
Controversial Healthineers rebranding launch
The launch of the Siemens Healthineers name attracted ridicule over the unusual wording, logo comparisons, and an elaborate dance performance. Bernd Montag later said that the dance presentation had been a mistake.
Source

Marketing campaigns

2016Siemens Healthineers brand launch
Global
Siemens introduced the Siemens Healthineers name in a global corporate rebranding of its healthcare division. The launch used a highly theatrical presentation in Erlangen, including a choreographed dance intended to communicate energy and innovation.
Outcome. The new identity was adopted, but the launch presentation and visual identity received widespread negative commentary in the business and popular press.
Source

Brand decisions

2022
Continuation of healthcare operations in RussiaStrategy
Background
Russia's invasion of Ukraine prompted many companies to leave or restrict their Russian businesses, while healthcare supply considerations remained a stated concern.
Action taken
Siemens Healthineers stated that it would maintain its presence and continue providing healthcare products and services in Russia.
Aftermath
The decision led to criticism from observers who viewed it as inconsistent with international efforts to isolate Russia economically.
Source
2018
Partial public offeringOther
Background
Siemens AG sought to create a separately traded healthcare technology company while retaining control.
Action taken
Siemens Healthineers listed on the Frankfurt Stock Exchange after Siemens AG sold a minority stake.
Aftermath
The company became a public medtech group while Siemens AG remained its majority shareholder.
Initial share price. €28.00 (First trading day, 16 March 2018)
Source
2016
Adoption of the Siemens Healthineers identityStrategy
Background
Siemens was implementing a new management strategy and sought a distinct identity for its healthcare business.
Action taken
The Siemens Healthcare division was rebranded Siemens Healthineers.
Aftermath
The brand became the identity of the healthcare business and later the publicly listed company, although the launch itself was heavily criticized.
Source
2011
Exit from linear acceleratorsStrategy
Background
The company faced cost pressures in the cancer-treatment equipment business and reassessed its oncology portfolio.
Action taken
Siemens discontinued its linear accelerators for cancer treatment and concentrated more strongly on diagnostic imaging in cancer care.
Aftermath
The decision narrowed the company's radiotherapy equipment activities while maintaining its broader presence in oncology imaging and treatment planning.
Source

Recent events

2026.10.23
Reported2026.10.23
NVIDIA and Siemens Healthineers collaborate on adaptive radiotherapy[3]NVIDIA与Siemens Healthineers合作推进自适应放射治疗healthcare-digital.com
NVIDIA and Siemens Healthineers announced a collaboration to explore adaptive radiotherapy using agentic AI, patient-specific simulation and robotic intelligence. Siemens Healthineers’ Varian cancer care business is involved.
2022.01.13
Reported2022.01.13
Ascend announces strategic relationship with Siemens Healthineers[4]Ascend宣布与Siemens Healthineers建立战略合作关系healio.com
Ascend announced a strategic relationship with Siemens Healthineers intended to increase testing capacity at Ascend’s new laboratory in Sunnyvale, California. The laboratory is expected to open in the second quarter of 2022.
2021.07.28
Reported2021.07.27
ScreenPoint Medical raises $28 million in Series C funding[5]ScreenPoint Medical 完成 2,800 万美元 C 轮融资prnewswire.com
ScreenPoint Medical announced that it had raised $28 million in Series C funding, led by Insight Partners, with participation from existing investors and University Radiology Group. The company said the funding would support commercial growth, research and development, and product-portfolio expansion.
2021.07.27
Reported2021.07.27
ScreenPoint Medical raises $28 million in Series C funding[6]ScreenPoint Medical 完成 2800 万美元 C 轮融资prnewswire.com
ScreenPoint Medical announced that it raised $28 million in Series C funding. Insight Partners led the round, with continued support from existing investors and participation from University Radiology Group.
2021.05.13
Reported2021.05.13
Genetron and Siemens Healthineers form strategic partnership for precision lung cancer diagnosis and treatment[7]泛生子与西门子医疗达成肺癌精准诊疗战略合作prnasia.com
Genetron and Siemens Healthineers announced a strategic partnership to promote wider use of Genetron's GENETRON S5 gene sequencer and lung cancer eight-gene test kit in Chinese hospitals, supporting precision diagnosis and treatment for lung cancer.
2021.04.15
Reported2021.04.15
Siemens Healthineers completes acquisition of Varian[8]Siemens Healthineers完成对Varian的收购itnonline.com
Siemens Healthineers announced that it completed its acquisition of Varian Medical Systems on April 15, 2021.
2021.04.01
Siemens Healthineers appoints Vivek Kanade as managing director in India[9]西门子医疗任命Vivek Kanade为印度董事总经理biospectrumindia.com
Vivek Kanade was named Managing Director of Siemens Healthcare Private Limited in India, effective April 1, 2021. He will continue to lead the Siemens Healthineers India business, including operations in the stated Zone India countries.
Unconfirmed
Reported2021.01.29
Siemens Healthineers NT-proBNP reagent launches in China[10]西门子医疗NT-proBNP检测试剂在中国获批上市prnasia.com
Siemens Healthineers’ NT-proBNP testing reagent was approved and launched in China, enabling BNP and NT-proBNP testing on one chemiluminescence platform.
2020.12.15
Reported2020.12.15
CorVent and Siemens Healthineers agree on U.S. ventilator distribution[11]CorVent与Siemens Healthineers达成美国呼吸机分销协议prnewswire.com
CorVent Medical announced an agreement with Siemens Healthineers for U.S. distribution of the RESPOND-19 ventilator to Siemens Healthineers' network of hospital, healthcare system and government customers.
2020.10.27
Reported2020.10.27
Imbio and Siemens Healthineers announce global partnership[12]Imbio与西门子医疗宣布全球合作prnewswire.com
Imbio and Siemens Healthineers announced a partnership to expand worldwide access to Imbio AI algorithms. Physicians can apply Imbio's automated AI image-analysis tools through the Open Apps interface on Siemens' syngo.via platform.